Radiotherapy is a highly effective, targeted therapy for the management of cancer.
Technological innovations have enabled the direct integration of imaging technology into …

With the emergence of individualized medicine and the increasing amount and complexity of
available medical data, a growing need exists for the development of clinical decision …

Abstract Purpose In 10–24% of patients with rectal cancer who are treated with neoadjuvant
chemoradiation, no residual tumor is found after surgery (ypT0). When accurately selected …

Objectives To assess the influence of region of interest (ROI) size and positioning on tumour
ADC measurements and interobserver variability in patients with locally advanced rectal …

This review summarizes current applications and clinical utility of diffusion-weighted imaging
(DWI) for rectal cancer and in addition provides a brief overview of more recent …

Purpose: To assess the value of diffusion‐weighted MR imaging (DWI) as a potential
noninvasive marker of tumor aggressiveness in rectal cancer, by analyzing the relationship …

After neoadjuvant radiochemotherapy (RCT) for locally advanced rectal cancer, 15–27% of
the patients experience a pathological complete response (pCR). This observation raises …

Purpose To determine the diagnostic performance of intravoxel incoherent motion (IVIM)
parameters and apparent diffusion coefficient (ADC) to assess response to combined …

Aim Approximately 20% of patients treated with neoadjuvant chemoradiotherapy (nCRT) for
locally advanced rectal cancer achieve a pathological complete response (p CR) while the …

PURPOSE: To evaluate diffusion-weighted magnetic resonance imaging (DWI) for response
prediction before and response assessment during and early after preoperative …